Title: FMid-Family Medicine – Infectious Diseases: HIV; STDs; Tuberculosis
Faculty: John Crane, M.D. Ph.D., Stephen J. Gluckman, M.D., F.A.C.P., F.I.D.S.A
Original Release Date: July 1, 2020 Expiration Date: July 1, 2023
TOPIC 1: What Every Primary Care Provider Should Know About HIV.
Upon completion of this session, the participant should be able to: GL, EBM, COMP
- Relate the present epidemiology of HIV.
- Develop an up-to-date understanding of the prognosis for a newly infected person.
- Assess the major viral and host factors that determine the present approach to the management of a person infected with HIV as per the NIH, CDC & IDSA Guidelines.
- Determine risk to health care workers and develop a plan to manage an exposed health care worker as per the current CDC and USPSTF Guidelines.
TOPIC 2: Sexually Transmitted Diseases.
Upon completion of this session, the participant should be able to: GL, COMP
- Relate the present epidemiology of STDs in this country.
- Develop a differential diagnosis and a diagnostic and treatment approach for the following STD syndromes based on CDC guidelines:
- Genital ulcer(s).
- Specify the diagnosis and management of syphilis, gonorrhea, chlamydia, herpes simplex, and HPV.
- Relate the proper use of a condom so that they may properly educate patients.
TOPIC 3: Tuberculosis: Latent and Active
Primary care providers play a significant part in achieving the target of TB elimination because of their access to high-risk populations in their practices. Using guidelines from the CDC, ATS and IDSA, an evidence-based approach on diagnosis and treatment will be reviewed. Upon completion of this session, the participant should be able to: EBM, GL, COMP
- Accurately explain to patients, family members, and other health care personnel the difference between active TB and latent TB
- Skillfully incorporate the use of interferon gamma release assays (IGRA’s) into testing for latent or active TB.
- Give an example of a special population for which a tuberculin skin test (TST) might still be used instead of an IGRA.
- Understand the changing epidemiology of non-TB mycobacteria in the U.S